Dr. Hira Thapliyal, Ph.D., got started in the medical device industry while developing a cauterizing, glass scalpel. A cardiovascular industry veteran, who played a critical role in the founding of companies such as atherectomy pioneer DVI (Devices for Vascular Intervention Inc.), and intravascular ultrasound leader CVIS (Cardiovascular Imaging Systems, now part of Boston Scientific Corp.).
Three years later he became CEO of MicroBionics, Inc. Thapliyal then founded a new company in April 1993 called ArthroCare Corporation, which used coblation technology to facilitate arthroscopic joint surgery. Dr. Thapliyal served as the company's initial president and chief executive officer.
Hira then co-founded and was CEO of Tescient, Inc. Hira is currently the President & CEO of VytronUS, Inc. VytronUS is developing products in cardiovascular field.
Hira is currently a member of the Board of Directors for Apsara Medical, Inc., Intact Medical, Inc., and PAVAD Medical, Inc. He is also the Special Partner of MedVenture Associates IV. Dr. Thapliyal is also an Advisory Board Member to the Department of BioEngineering at University of California, Berkeley and Materials Science and Engineering at Cornell University.
Dr. Hira Thapliyal earned his B.S. in electrical engineering from Washington State University, followed by an M.S. in electrical engineering from the University of Idaho and a Ph.D. in materials science and engineering from Cornell University.
